Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab[4] Abatacept,
Rituximab,
Sarilumab (Sarilumab),
Tocilizumab		[4] Tocilizumab ,
Rituximab ,
Abatacept ,
Sarilumab (Sarilumab) 💬 		[4] CD80,
CD86,
IL6R,
MS4A1 💬 		[25] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Coronavirus disease, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬[1] 46 💬
2SARILUMAB[1] Sarilumab (Sarilumab)[1] Sarilumab (Sarilumab) 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[5] 41, 46, 84, 107, 271 💬
3Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA][1] Sarilumab (Sarilumab)[1] Sarilumab (Sarilumab) 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
4Sarilumab SAR153191[1] Sarilumab (Sarilumab)[1] Sarilumab (Sarilumab) 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41 💬
5Sarilumab SAR153191 (REGN88)[1] Sarilumab (Sarilumab)[1] Sarilumab (Sarilumab) 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 107 💬
6SarilumabProduct Code: SAR153191 (REGN88)Pharmaceutical Form: Solution for injectionINN or Proposed INN: SARILUMABCurrent Sponsor code: SAR153191Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 175-----[1] 107 💬
7Tocilizumab or sarilumab[2] Sarilumab (Sarilumab),
Tocilizumab		[2] Tocilizumab ,
Sarilumab (Sarilumab) 💬 		[1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬